108 related articles for article (PubMed ID: 24184983)
1. Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
Germi R; Mariette C; Alain S; Lupo J; Thiebaut A; Brion JP; Epaulard O; Saint Raymond C; Malvezzi P; Morand P
Antiviral Res; 2014 Jan; 101():57-61. PubMed ID: 24184983
[TBL] [Abstract][Full Text] [Related]
2. Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
Kleiboeker H; Descourouez JL; Schulz LT; Mandelbrot DA; Odorico JS; Saddler CM; Smith JA; Jorgenson MR
Transplant Proc; 2024 Mar; 56(2):434-439. PubMed ID: 38355369
[TBL] [Abstract][Full Text] [Related]
3. Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighting the Role of Advanced Practice Providers (Nurse Practitioners and Physician Assistants).
Cochran WV; Dioverti MV; Langlee J; Barker LN; Shedeck A; Toman LP; Avery RK
Ann Transplant; 2024 Apr; 29():e941185. PubMed ID: 38650316
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease.
Sadowska-Klasa A; Leisenring WM; Limaye AP; Boeckh M
J Infect Dis; 2024 May; 229(5):1435-1439. PubMed ID: 37682870
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease.
Karaba AH; Figueroa A; Werbel WA; Dioverti MV; Steinke SM; Ray SC; Cox AL; Avery RK
Transpl Infect Dis; 2021 Aug; 23(4):e13682. PubMed ID: 34216086
[TBL] [Abstract][Full Text] [Related]
6. Incidence of refractory CMV infection with or without antiviral resistance in Spain: A systematic literature review.
Aguado JM; Navarro D; Montoto C; Yébenes M; de Castro-Orós I
Transplant Rev (Orlando); 2024 Jan; 38(1):100804. PubMed ID: 37949797
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Loft JA; Riis PT; Schultz NA; Bjerrum S; Schønning K; Pedersen CR; Krohn PS; Nielsen SD
Ugeskr Laeger; 2024 Apr; 186(15):. PubMed ID: 38708697
[TBL] [Abstract][Full Text] [Related]
8. Maribavir failure in refractory cytomegalovirus infection in a lung transplant patient on extracorporeal membrane oxygenation.
Kroll C; Non L; Ince D
Transpl Infect Dis; 2024 Jun; 26(3):e14275. PubMed ID: 38584587
[No Abstract] [Full Text] [Related]
9. Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study.
Mott BT; He R; Chen X; Fox JM; Civin CI; Arav-Boger R; Posner GH
Bioorg Med Chem; 2013 Jul; 21(13):3702-7. PubMed ID: 23673218
[TBL] [Abstract][Full Text] [Related]
10. Organizing Pneumonia due to Secondary Invasive Pulmonary Mycosis and Cytomegalovirus Infection in a Patient with Lymphoma.
Luo JF; Li XR; Ji HL; Nie CX; Ge YL; Fu AS
Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868889
[TBL] [Abstract][Full Text] [Related]
11. Development of cytomegalovirus resistant to maribavir: real world, real problem?
Kleiboeker HL; Prom A; Paplaczyk K
Transpl Infect Dis; 2024 Apr; 26(2):e14259. PubMed ID: 38430481
[No Abstract] [Full Text] [Related]
12. Combination therapy for multidrug-resistant cytomegalovirus disease.
Stuehler C; Stüssi G; Halter J; Nowakowska J; Schibli A; Battegay M; Dirks J; Passweg J; Heim D; Rovo A; Kalberer C; Bucher C; Weisser M; Dumoulin A; Hirsch HH; Khanna N
Transpl Infect Dis; 2015 Oct; 17(5):751-5. PubMed ID: 26432076
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
Verkaik NJ; Hoek RA; van Bergeijk H; van Hal PT; Schipper ME; Pas SD; Beersma MF; Boucher CA; Jedema I; Falkenburg F; Hoogsteden HC; van den Blink B; Murk JL
Transpl Infect Dis; 2013 Dec; 15(6):E243-9. PubMed ID: 24298985
[TBL] [Abstract][Full Text] [Related]
14. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.
Kotton CN; Kumar D; Caliendo AM; Huprikar S; Chou S; Danziger-Isakov L; Humar A;
Transplantation; 2018 Jun; 102(6):900-931. PubMed ID: 29596116
[TBL] [Abstract][Full Text] [Related]
15. Anti-CMV therapy, what next? A systematic review.
Gourin C; Alain S; Hantz S
Front Microbiol; 2023; 14():1321116. PubMed ID: 38053548
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: a diagnostic and therapeutic approach to antiviral resistance.
Hume J; Sweeney EL; Lowry K; Fraser C; Clark JE; Whiley DM; Irwin AD
Front Pediatr; 2023; 11():1180392. PubMed ID: 37325366
[TBL] [Abstract][Full Text] [Related]
17. Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review.
Hiskey L; Madigan T; Ristagno EH; Razonable RR; Ferdjallah A
Front Pediatr; 2022; 10():1039938. PubMed ID: 36507142
[TBL] [Abstract][Full Text] [Related]
18. A rapid evidence assessment exploring whether antimicrobial resistance complicates non-infectious health conditions and healthcare services, 2010-20.
Hocking L; Ali GC; d'Angelo C; Deshpande A; Stevenson C; Virdee M; Guthrie S
JAC Antimicrob Resist; 2021 Dec; 3(4):dlab171. PubMed ID: 34806009
[TBL] [Abstract][Full Text] [Related]
19. In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients.
Karami S; Roshandel E; Ghaffari Nazari H; Hajifathali A; Tavakoli F; Parkhideh S
Virusdisease; 2021 Sep; 32(3):422-434. PubMed ID: 34631973
[TBL] [Abstract][Full Text] [Related]
20. Small Molecules-Prospective Novel HCMV Inhibitors.
Bogner E; Egorova A; Makarov V
Viruses; 2021 Mar; 13(3):. PubMed ID: 33809292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
